Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
83.10
-1.69 (-1.99%)
At close: Jan 23, 2026, 4:00 PM EST
82.67
-0.43 (-0.52%)
After-hours: Jan 23, 2026, 6:25 PM EST
Protagonist Therapeutics Market Cap
Protagonist Therapeutics has a market cap or net worth of $5.2 billion as of January 23, 2026. Its market cap has increased by 126.71% in one year.
Market Cap
5.20B
Enterprise Value
4.53B
1-Year Change
126.71%
Ranking
Category
Stock Price
$83.10
Market Cap Chart
Since August 11, 2016, Protagonist Therapeutics's market cap has increased from $171.50M to $5.20B, an increase of 2,929.18%. That is a compound annual growth rate of 43.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 5.20B | -4.85% |
| Dec 31, 2025 | 5.46B | 137.34% |
| Dec 31, 2024 | 2.30B | 73.94% |
| Dec 29, 2023 | 1.32B | 146.39% |
| Dec 30, 2022 | 536.80M | -67.11% |
| Dec 31, 2021 | 1.63B | 111.63% |
| Dec 31, 2020 | 771.30M | 302.14% |
| Dec 31, 2019 | 191.80M | 17.81% |
| Dec 31, 2018 | 162.80M | -61.78% |
| Dec 29, 2017 | 426.00M | 15.89% |
| Dec 30, 2016 | 367.60M | 114.34% |
| Aug 11, 2016 | 171.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kymera Therapeutics | 5.59B |
| Cogent Biosciences | 5.58B |
| Crinetics Pharmaceuticals | 5.45B |
| CRISPR Therapeutics AG | 5.29B |
| Immunovant | 5.27B |
| Celcuity | 5.09B |
| Mirum Pharmaceuticals | 4.87B |
| Apogee Therapeutics | 4.73B |